Masquelier is a medical doctor MD with a specialisation in endocrinology and holds an MBA in marketing/management. She started her career as a medical practitioner before moving to the healthcare industry where she held various management positions in pharmaceutical, CRO and biotech companies. Most recently she was general manager of Genethon.
Masquelier will manage CSD’s established medical research teams in France, Germany, Italy, Spain and UK, China, Japan and the US. She will continue the expansion of this activity in all of the 39 countries where CSD is present.
Anne-Marie Masquelier joins Cegedim Strategic Data
Takes role of global medical research director
You may also like
Research & Development
Weight loss drugs such as Ozempic may prevent stroke and reduce brain injury related complications
Three studies presented at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether using GLP-1 inhibitors could lessen the impacts of stroke and related brain injuries or reduce the risk of stroke altogether
Finance
Sanofi completes acquisition of Blueprint Medicines
Sanofi announces the completion of its acquisition of Blueprint Medicines Corporation, adding to its portfolio a commercialised medicine and the expertise of a company specialising in systemic mastocytosis (SM) and other KIT-driven diseases